
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
TELO | TSXV | CAD | Delayed | |
TDSGF | OTC Markets | USD | Delayed | |
TELO | CBOE Canada | CAD | Real-time |
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada. Its TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability to identify specific disease mechanisms, predict disease risks, and determine effective treatments. Its lead product is TeloView-SMM (Smoldering Multiple Myeloma) for SMM patients with high risk of transition to multiple myeloma (MM). The company also develops TeloView NDMM that predicts newly diagnosed MM patients who may relapse on 1st line therapy; TeloMRD-D Enumaeration that identifies and enumerates MRD cells in post-transplant patients; and TeloViewNG-MRD (Minimal Residual Disease) Profiling for genomic instability profiling of MRD detected cells in post-transplant patients. It has a collaboration agreement with the Mayo Clinic. Telo Genomics Corp. is headquartered in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
Hans Knecht | - | - | Member of Clinical & Scientific Advisory Board |
Sabine Mai | - | 2016 | Founder, Interim CEO, Chair of the Clinical & Scientific Advisory Board and Director |
Guido Baechler | 60 | 2019 | Executive Chairman |
William John Meekison | 60 | 2020 | Independent Director |
Ronald C. McGlennen | - | 2022 | Independent Director |
Ivan M. Borrello | 61 | 2024 | Member of Clinical Advisory Board |
David Samuel diCapua Siegel | - | 2024 | Member of Clinical Advisory Board |
James R. Berenson | - | 2024 | Member of Clinical Advisory Board |
Shaji K. Kumar | - | 2024 | Member of Clinical Advisory Board |
Kenneth C. Anderson | 74 | 2016 | Member of Clinical & Scientific Advisory Board |
Hans Knecht | - | 2016 | Medical laboratory Director & Member of Clinical Advisory Board |
Hugh A. D. Rogers | 45 | 2015 | Independent Director |
John Allen Farlinger | 66 | 2025 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review